AI Insight
SAMP V2 is a computational machine learning model designed to identify antimicrobial peptides (AMPs), which are promising alternatives to conventional antibiotics for treating drug-resistant infections. The model improves upon its predecessor by dividing peptides into three regions (N-terminal, middle, and C-terminal) and incorporating biochemical properties and sequence-order information alongside amino acid composition. When tested on six independent datasets, SAMP V2 outperformed existing state-of-the-art models across multiple performance metrics including accuracy, MCC, G-measure, and F1-score.
Why it matters
This tool could accelerate the discovery of new antimicrobial therapeutics to combat the growing global threat of antibiotic-resistant bacteria by reducing the time and cost associated with traditional laboratory-based screening of antimicrobial peptides. Faster computational identification of promising AMP candidates could help address one of the most pressing challenges in modern medicine.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Antimicrobial resistance reduces the effectiveness of conventional antibiotics and has become a major global health threat, highlighting the need for new anti-infective agents. Antimicrobial peptides (AMPs), a diverse class of innate immune effectors with broad-spectrum antimicrobial activity, are promising candidates for combating drug-resistant infections. Identifying AMPs by wet-lab experiments, however, remains costly and time-consuming, creating a strong demand for computational identification methods. Our recently developed method, SAMP, captures region-specific residue distributions based on proportionalized split amino acid composition. However, SAMP might ignore key biochemical information and sequence order information. Here we present SAMP V2, a stacking ensemble learning framework based on biochemical and sequence-order information augmented split amino acid composition (BIA-SAAC), which extends SAMP by integrating pseudo-amino acid composition features with biochemical and sequence-order information into split peptide regions. Specifically, each peptide is divided into N-terminal, middle, and C-terminal regions, and pseudo amino acid composition is calculated within each region. Benchmarking tests on six independent test datasets, SAMP V2 outperformed multiple state-of-the-art models, including AMPpred-MFA and iAMP-Attenpred, in terms of accuracy, MCC, G-measure and F1-score. Given its high and robust performance, SAMP V2 could significantly accelerate the discovery of next-generation antimicrobial therapeutics for addressing the global threat of multidrug-resistant pathogens.